Longboard Pharmaceuticals
(NASDAQ) LBPH
Longboard Pharmaceuticals Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$8.00K
Net Income (TTM)
$76.34M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
LBPH News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Longboard Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
50
CEO
Kevin R. Lind, MBA
Website
www.longboardpharma.comHeadquarters
La Jolla, CA 92037, US
LBPH Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-1%
Return on Capital
-1%
Return on Assets
-1%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$5.00K
Operating Income
$56.76M
EBITDA
$56.75M
Operating Cash Flow
$50.87M
Capital Expenditure
$0.00
Free Cash Flow
$50.87M
Cash & ST Invst.
$48.50M
Total Debt
$475.00K
Longboard Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
+100.0%
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
50
N/A
Net Income
$24.54M
-89.7%
EBITDA
$28.12M
-107.1%
Quarterly Fundamentals
Net Cash
$284.71M
+412.9%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$3.47M
+3110.2%
Short Term Debt
$267.00K
-32.2%
Return on Assets
-1.07%
N/A
Return on Invested Capital
-1.39%
N/A
Free Cash Flow
$20.59M
-55.0%
Operating Cash Flow
$20.59M
-55.0%